| |
siRNA Id: | aspsirna0653
|
siRNA Name: | SiRNA-A13
|
Gene: | Potasium channel voltage-gated subfamily h member 2(KCNH2) |
Disease: | Long QT Syndrome (LQTS) |
Wild allele/target (5'->3'): | ACCCUACUCGGCUGCCUUC
|
Mutant allele/target (5'->3'): | ACCCUAUUCGGCUGCCUUC
|
Target Mutation: | c.1682C>T ,p.Ala561Val
|
Wild siRNA (As strand): | UGGGAUGAGCCGACGGAAG
|
ASP-siRNA (As strand): | UGGGAUAAGCCGACGGAAG
|
Mismatch position in siRNA: | A13G |
Mutant allele (5'->3'): | ACCCUAUUCGGCUGCCUUC
|
ASP-siRNA (As strand): | UGGGAUAAGCCGACGGAAG
|
ASP-siRNA efficacy for mutant allele: | 48
|
Wild allele (5'->3'): | ACCCUACUCGGCUGCCUUC
|
ASP-siRNA (As strand): | UGGGAUAAGCCGACGGAAG
|
ASP-siRNA efficacy for wild allele: | 10
|
Percentage discrimination for ASP-siRNA: | 38
|
Wild allele (5'->3'): | ACCCUACUCGGCUGCCUUC
|
Wild siRNA (As strand): | UGGGAUGAGCCGACGGAAG
|
Wild sirna efficacy for wild allele: | NA
|
Wild allele (5'->3'): | ACCCUACUCGGCUGCCUUC
|
ASP-siRNA (As strand): | UGGGAUAAGCCGACGGAAG
|
Wild sirna efficacy for mutant allele: | NA
|
Percentage discrimination for wild siRNA: | NA
|
Concentration: | 20microM |
Orientation: | Sense |
Mismatch in: | siRNA |
UniProt ID: | Q12809 |
Target sequence: | ACTCGGCTGCCTTCCTGCTGAAGGAGACGG |
Genbank Accesion: | NM_001204798.1 |
Cell-line: | cardiomyocytes |
Experimental technique used: | RT-PCR, Flourescence microscopy |
Transfection method: | Lipofectamine 2000 |
siRNA expression method: | Invitrogen |
Post-transfection duration: | 72 hours |
OMID ID: | 152427 |
KEGG disease ID: | H00720 |
Reference: | 23470493 |